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A b s t r a c t  
In the present paper, we provide an insight of the radioprotective potential of Adhatoda vasica leaf 
extract. Mice bone marrow cells were used as the test system. Animals were fed with 500mg/kg 
body wt. and 1000mg/kg body wt. of ethanolic extract of the plant prior to 9 Gray γ-radiation 
exposure and chromosomal aberration assay and micronucleus assay were performed. The 
frequency of chromosomal aberrations and micronuclei among different treatment groups and the 
controls was compared. The results revealed a significant decrease in the frequency of 
chromosomal aberrations as well as the micronucleus possessing cells in the groups pre-treated 
with A. vasica extract as compared to the untreated group. Better radioprotection was observed in 
1000mg/kg-body wt. dosage group as compared to 500mg/kg-body-wt. dosage group. These 
findings were suggestive of radioprotective potential of A. vasica leaf extract.  
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Introduction 
Radiotherapy is one of the most common modalities followed for 
treating human cancers [1]. Together with other modalities such as 
surgery and chemotherapy, it plays an important role in the 
treatment of 40% of those patients who are cured of their cancer [2]. 
Radiotherapy is also a highly effective treatment option for palliation 
and symptom control in cases of advanced or recurrent cancers. To 
obtain optimum results, a judicious balance between the total dose 
of radiotherapy delivered and the threshold limit of the surrounding 
normal critical tissues is required. In order to obtain better tumor 
control with a higher dose, the normal tissues need to be protected 
against radiation injury. Aqueous radiolysis caused by ionizing 
radiation generates free radicals which may interact directly or 
indirectly with the genetic material causing damage and subsequent 
cell death. [3] Thus, the role of radioprotective compounds is very 
important in clinical radiotherapy. Evidence suggests that various 
compounds and formulations are being used as adjuvants to 
radiotherapy in order to minimize its harmful effects on the normal 
tissues. In addition, researchers have explored numerous plant 
materials as potential radioprotectors. The radioprotective potential 
of several herbal plants is well established and the noteworthy 
studies include those on Gingko biloba [4], Ocimum sanctum [5], 
Panax ginseng [6], Tinospora cordifolia [7], Emblica officinalis [8], 
Piper longum [9], Mentha piperita [10], and Zingiber officinale [11]. 
Adhatoda vasica, an evergreen, gregarious, stiff and perennial 
shrub of family Acanthaceae has been used as herbal medicine in 
treating a wide variety of diseases in India. Leaves of the plant are 
the main source of drug preparation. A number of different 
principles including, alkaloids: vasicine, vasicinone, vasinol, 
essential oil: betane, vitamins: vitamin C, b-carotene, a non-
crystalline steroid: vasakin and a mixture of fatty acids have been 
identified as contributing to the observed medicinal effects of the 
plant [12]. The shrub is the source of the drug ‘vasaka’, well known 
in the indigenous system of medicine for its beneficial effects, 
particularly in bronchitis. Furthermore, A. vasica has also been 
accredited to afford protection against allergen-induced bronchial 
obstruction in guinea pigs [13]. The leaves as well as flowers, fruits 
and roots are extensively used for treating cold, whooping cough, 
asthma and as antihelminthic. The leaf juice is stated to cure 
diarrhoea, dysentry and glandular tumor. In vivo investigations have 
revealed that 90% ethanolic extract of A. vasica possesses 
promising teratologic effects in rats [14]. Bromohexine and 
ambroxol, semisynthetic derivatives of vasicine from A. vasica have 
growth inhibitory effect on Mycobacterium tuberculosis, thereby 
proving useful in the therapy of tuberculosis [15]. In the context of 
the aforementioned literature, the present study is aimed at 
investigating the radioprotective potential of A. vasica leaf extract 
using Swiss albino mice.  
 
Material and Methods 
Collection and Identification of plant 
A. vasica plants were collected from areas in and around Bhopal, 
Madhya Pradesh (India). Samples were identified at Department of 
Botany, MLB College, Bhopal. 
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Extraction 
A. vasica leaves were washed thoroughly, shade-dried and finely 
powdered in a mixer. Extraction, using 80% ethanol solvent system 
[16], was performed in order to obtain the leaf extract, which was 
then lyophilized, weighed and stored for further usage.  
Animals 
Female Swiss albino mice, 6-8 weeks old with an average body 
weight of 30 gm, from an inbred colony were obtained from 
CPCSEA approved animal breeding centre of Jawaharlal Nehru 
Cancer Hospital & Research Centre, Idgah Hills, Bhopal. These 
were maintained under controlled temperature and light conditions 
in an animal house and provided with standard diet and acidified 
water ad libitum. 
Irradiation 
Cobalt-60 gamma radiation unit of Radiotherapy Department, 
Jawaharlal Nehru Cancer Hospital & Research Centre, Idgah Hills, 
Bhopal, was used for whole body irradiation of mice. Single fraction 
dose of 9 Gy gamma radiation was used. 
 
 
Table 1 shows the animal groups and the respective treatments provided. 
Groups Number of 
Mice 
Treatment 
(6 days duration) 
Irradiation 
(Post treatment) 
Normal Control (NC) 4 No drug No radiation 
Vehicle Control (VC) 4 2% gum acacia No radiation 
Radiation Control (RC) 4 No drug 9Gy gamma 
radiation 
Drug Dose 1 (D1) 4 500 mg extract/ kg-body wt.  No radiation 
Drug Dose 2 (D2) 4 1000 mg extract/ kg-body wt.  No radiation 
Radiation + Drug1 (RD1) 4 500 mg extract/ kg-body wt. 9Gy gamma 
radiation 
Radiation + Drug2 (RD2) 4 1000 mg extract/ kg-body wt. 9Gy gamma 
radiation 
 
 
Bone Marrow Chromosomal Aberration Assay [17] 
All the animals were sacrificed by cervical dislocation after 2 hours 
of intraperitoneal colchicine (0.025%) injection. The femoral bone 
was excised and the bone marrow was aspirated by flushing it with 
normal saline. The cells were centrifuged and treated with 0.056M 
KCl solution at 37°C for 30 minutes. The cell pellet was fixed with 
freshly prepared acetic acid-methanol solution. The pellet was 
washed and finally resuspended in 2ml of the fixative. The slides 
were prepared by standard air drop method and stained with 4% 
Giemsa stain [18]. The slides were observed under 100X 
magnification of BX60 Olympus microscope. The chromosomal 
aberrations were observed and recorded in standard format.  
Bone Marrow Micronucleus Assay 
For micronucleus assay the bone marrow cells were washed with 
normal saline and fixed with freshly prepared acetic acid-methanol 
solution. The cells were centrifuged and repeatedly washed with 
the fixative prior to slide preparation. The slides were prepared by 
smearing and stained with 4% Giemsa stain. The dried slides were 
observed under 100X magnification of BX60 Olympus microscope 
and the micronuclei were scored. 
Statistical Analysis 
The data was analyzed by performing One-way ANOVA by using 
GraphPad Prism version 4 software. 
 
Results 
Chromosomal Aberration Assay 
Chromosomal aberrations (Figure 1) were found to be significantly 
increased in RC group as compared to the NC group (p<0.001). 
The mean aberrant metaphases in the RD1 and RD2 groups were 
observed to be statistically increased as compared to NC group. 
However, the incidence of mean aberrant metaphases in RD2 
group to be significantly decreased as compared to the RC group. 
The mean aberrant metaphases in the VC, D1 and D2 groups 
were observed to be statistically non-significant (p>0.05) as 
compared to the NC group. The mean incidence of chromosomal 
aberrations observed in various groups is given in Table 2. 
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Table 2. Frequency of chromosomal aberrations in mice bone marrow cells of treatment and control groups. 
 
Group
s 
 
NM 
(Mean ± 
S.E.) 
 
AM 
(Mean ± 
S.E.) 
Types of Aberrations 
(Mean ± S.E.) 
MIN R ACA DC F ICD PCD PP 
NC 26.75±0.4
8 
3.25±0.48 0.75±0.25 0.0±0.0 1.5±0.29 0.0±0.0 1.0±0.41 0.0±0.0 0.0±0.0 0.0±0.0 
VC 26.25±0.4
8 
3.75±0.48 1±0.41 0.0±0.0 1.5±0.29 0.0±0.0 1.25±0.48 0.0±0.0 0.0±0.0 0.0±0.0 
RC 3.75±0.63 26.25±0.63* 12.75±2.5
6 
7.0±1.29 8.25±1.3
1 
14.0±2.1
6 
13.25±0.9
5 
0.25±0.6
3 
2.75±0.4
8 
1.75±0.2
5 
D1 23.75±0.6
3 
6.25±0.63 2.75±0.48 0.50±0.2
9 
4.50±0.6
5 
2.2±0.25 1.75±0.48 2.0±0.41 0.0±0.0 0.0±0.0 
D2 24.0±0.71 6.0±0.71 1.5±0.29 0.5±0.29 3.5±0.29 1.25±0.6
5 
1.5±0.65 1.0±0.41 0.0±0.0 0.0±0.0 
RD1 7.75±0.85 22.25±0.85* 11.0±1.08 6.75±0.6
3 
7.75±0.7
5 
7.25±0.2
5 
4.5±0.65 1.0±0.65 0.50±0.2
9 
0.0±0.0 
RD2 19.5±1.11 10.25±1.11*
y 
8.75±0.48 3.75±0.4
8 
2.25±0.6
5 
3.25±0.6
3 
0.5±0.29 0.25±0.2
5 
0.0±0.0 0.25±0.2
5 
* Significant when compared to normal control group (P<0.001) 
y Significant when compared to radiation alone group 
 
Table 3. Frequency of micronucleus possessing cells in mice bone marrow cells of treatment and control groups. 
 
Group Number of Cells scored Normal Cells 
(Mean ± S.E.) 
Micronuclei Cells 
(Mean ± S.E.) 
NC 100 99.00 ± 0.41 1.0 ± 0.41 
VC 100 99.00 ± 0.41 1.0 ± 0.41 
RC 100 44.25 ± 1.89  56.0 ± 1.73* 
D1 100 95.0 ± 0.71 5.0 ± 0.71 
D2 100 97.25 ± 0.25 2.75 ± 0.25 
RD1 100 78.75 ± 1.03 21.25 ± 1.03*y 
RD2 100 89.25 ± 0.63 10.75 ± 0.63*y 
* Significant when compared to normal control group (P<0.001). 
y Significant when compared to radiation alone group. 
 
Micronucleus Assay 
The mean number of micronucleus possessing cells (Figure 2) in 
RC, RD1 and RD2 groups was recorded to be significantly 
increased (p< 0.001) as compared to NC group. However, that of 
VC, D1 and D2 groups was found to be statistically non-significant 
as compared to the NC group.  A marked decrease (p<0.001) in the 
number of micronuclei of RD1 and RD2 groups was seen when 
compared to that of RC group micronuclei. Table 3 represents the 
mean incidence of micronucleus possessing cells found in different 
groups. 
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Figure 1: Chromosomal aberrations in the radiation exposed groups. 
a- metaphase showing acrocentric association, b- metaphase with a chromatid  break, c-severely damaged 
metaphase (pulverization) 
 
 
 
 
Figure 2 : Mice bone marrow cell with a micronucleus 
 
a b 
c 
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Discussion and Conclusion 
Ionising radiation is a known genotoxic agent [3]. The results of 
the present study revealed significantly increased chromosomal 
aberrations in the RC group as compared to NC group. The 
various aberrations observed include single and double minutes, 
rings acrocentric associations, fragments, interchromatid breaks, 
premature centromeric division and polyploidy. However, marked 
decrease in the mean aberrant metaphases was recorded in the 
groups pre-treated with A. vasica extract. Moreover, the extract 
could provide better radioprotection at 1000mg/kg-body wt. as 
compared to 500mg/kg-body-wt. dosage. The findings of 
chromosomal aberration assay were analogous to that of Meenal 
et al (2007), who concluded from their study that A. vasica is an 
effective radioprotector at the dosage of 800 mg/kg-body wt., 
administered for 15 days prior to 8Gy whole body radiation 
exposure [16]. However, in our study, a similar effect was 
observed after 6 day pre-treatment with 1000 mg/kg-body wt. 
dose of A. vasica extract in 9 Gy whole body radiation exposed 
group.  
In another study, Kumar et al (2005)  investigated the modulatory 
influence of A. vasica leaf extract in γ-irradiated Swiss albino 
mice by performing hematological and biochemical analyses 
including GSH assay, lipid peroxidation assay and serum 
phosphatases activity [19]. They concluded that a significant 
radioprotection is achieved at 800 mg/kg body-wt/day for 7 
consecutive days prior to 8 Gy γ-radiation. Ample evidence 
suggests that ionizing radiation results into the generation of free 
radicals due to radiolysis of water in a biological system (Hall, 
1978) [20]. GSH being an endogenous free radical scavenging 
enzyme offers protection against oxygen-derived free radicals 
and cellular lethality following exposure to ionizing radiation 
(Biaglow et al, 1987) [21]. However, marked reduction in blood 
GSH following radiation exposure has been revealed by Kumar et 
al (2005). The GSH reduction is minimized by pretreatment with 
A. vasica leaf extract. The decrease in the chromosomal damage 
exhibited by the A. vasica pretreatment group of our study may 
thus be attributed to the restoration of glutathione and the 
subsequent scavenging of free radicals generated on exposure to 
γ-radiation. To conclude, the findings of the present study unveil 
the fact that A. vasica has a potential radioprotective property. 
However, the role of the individual phyto-constituents needs to be 
explored for further validation, so that an alternative 
radioprotective therapeutic agent may be developed. 
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